Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Azari 80 versus Edarbi 80 under fasting conditions in healthy volunteers
TCTR20240616002Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azilsartan medoxomil (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 1 more. Started Sep 2024; status: completed.
02
Drugs
azilsartan medoxomil
Beyond the preview
Go deeper on TCTR20240616002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240616002.